Abstract
Naloxone is a highly specific, high-affinity opioid antagonist used to reverse the effects of opioids. It is available in several formulations for convenient administration by medical trained personnel and by lay persons in the ambulatory setting. Naltrexone is available orally or by long acting intramuscular injection for alcohol or opioid dependence disorders. With rising opioid misuse, abuse, addiction, and overdose deaths across the nation, increasing access to these products is vital to successfully managing the opioid epidemic.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dowell D, Haegerich T, Chou R. CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Recomm Rep. 2016;65(RR-1):1–49.
Gold Standard, Inc. Naloxone. Clinical Pharmacology [database online]. Available at http://www.clinicalpharmacology.com. Accessed 30 Oct 2017.
Wolters Kluwer Clinical Drug Information, Inc. Lexi-Drugs [database online]. Accessed 30 Oct 2017.
Using the LMA MAD Nasal Mucosal Atomization Device. 2017. https://www.teleflex.com/usa/product-areas/anesthesia/atomization/mad-nasal-device/. Accessed 30 Oct 2017.
Gold Standard, Inc. Naltrexone. Clinical Pharmacology [database online]. Available at http://www.clinicalpharmacology.com. Accessed 30 Oct 2017.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Albert, C.A. (2019). Naloxone and Naltrexone. In: Abd-Elsayed, A. (eds) Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-99124-5_66
Download citation
DOI: https://doi.org/10.1007/978-3-319-99124-5_66
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99123-8
Online ISBN: 978-3-319-99124-5
eBook Packages: MedicineMedicine (R0)